Shares of Catasys, Inc. (NASDAQ:CATS) have been given an average broker rating score of 2.00 (Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy rating. Catasys’ rating score has declined by 33.3% in the last three months as a result of various analysts’ upgrades and downgrades.

Brokers have set a 1-year consensus price objective of $5.30 for the company and are forecasting that the company will post ($0.09) EPS for the current quarter, according to Zacks. Zacks has also assigned Catasys an industry rank of 208 out of 265 based on the ratings given to related companies.

Several analysts have issued reports on the stock. Taglich Brothers assumed coverage on shares of Catasys in a research note on Wednesday, October 18th. They issued a “speculative buy” rating and a $8.00 price objective for the company. Telsey Advisory Group began coverage on shares of Catasys in a research report on Wednesday, October 18th. They set a “buy” rating on the stock. ValuEngine lowered shares of Catasys from a “hold” rating to a “sell” rating in a research report on Saturday, October 21st. Finally, Zacks Investment Research lowered shares of Catasys from a “hold” rating to a “sell” rating in a research report on Tuesday, December 19th.

Shares of Catasys (NASDAQ:CATS) traded up $0.02 during midday trading on Friday, reaching $5.00. 72,024 shares of the company’s stock traded hands, compared to its average volume of 75,632. The company has a market capitalization of $79.13, a P/E ratio of -2.86 and a beta of -0.29. Catasys has a twelve month low of $3.30 and a twelve month high of $14.00.

Catasys (NASDAQ:CATS) last announced its quarterly earnings data on Tuesday, November 14th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.15) by ($0.04). equities research analysts predict that Catasys will post -0.89 EPS for the current year.

An institutional investor recently bought a new position in Catasys stock. UBS Oconnor LLC bought a new position in shares of Catasys, Inc. (NASDAQ:CATS) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 182,597 shares of the company’s stock, valued at approximately $834,000. UBS Oconnor LLC owned 1.15% of Catasys as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 6.29% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Catasys, Inc. (CATS) Receives Average Recommendation of “Buy” from Analysts” was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at

Catasys Company Profile

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with's FREE daily email newsletter.